Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma × Immunotherapy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 36 Melanoma 14 Neoplasm Metastasis 13 Lung Neoplasms 12 Esophageal Neoplasms 10 Carcinoma, Hepatocellular 10 Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 7 Colorectal Neoplasms 7 Breast Neoplasms 7 Esophageal Squamous Cell Carcinoma 6 Stomach Neoplasms 5 Rectal Neoplasms 5 Head and Neck Neoplasms 5 Triple Negative Breast Neoplasms 4 Small Cell Lung Carcinoma 4 Uterine Cervical Neoplasms 3 Recurrence 3 Pancreatic Neoplasms 3 Multiple Myeloma 3 Liver Neoplasms 3 Cholangiocarcinoma 3 Brain Neoplasms 3 Sarcoma 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pathologic Complete Response 2 Neuroblastoma 2 Neoplasm, Residual 2 Locally Advanced Non-small Cell Lung Cancer 2

Interventions

Cyclophosphamide 380 Rituximab 328 Etoposide 190 Vincristine 175 Filgrastim 172 Doxorubicin 169 Prednisone 142 Radiotherapy 135 Cytarabine 133 fludarabine phosphate 120 Melphalan 110 Methotrexate 109 Peripheral Blood Stem Cell Transplantation 107 fludarabine 100 Busulfan 85 Dexamethasone 74 Carmustine 63 Granulocyte Colony-Stimulating Factor 60 Tacrolimus 59 Mycophenolic Acid 56 Gemcitabine 56 Whole-Body Irradiation 55 Bendamustine Hydrochloride 55 Antilymphocyte Serum 54 Lenalidomide 52 Cyclosporine 51 Ifosfamide 50 Bortezomib 48 Methylprednisolone 42 Leucovorin 39

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06202885 2024-01-12

CAREMM-2306: Advanced Immunotherapy vs. Classical Immunotherapy

Seoul St. Mary's Hospital

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡